Kaya A O, Coskun U, Yildiz R, Gonul I I, Karagulle K, Yaman E, Ozturk B
Department of Medical Oncology, Gazi University Medical School, Gazi hospital, Ankara, Turkey.
J BUON. 2009 Oct-Dec;14(4):703-6.
Primary pure small cell carcinoma of the urinary bladder (SCCB) is an extremely rare tumor and accounts for less than 1% of all malignant tumors of the urinary bladder. This tumor exhibits more aggressive behavior than bladder transitional cell carcinoma. Unfortunately, optimal treatment strategy for this malignancy is still unknown. We present a patient with metastatic primary pure SCCB (stage IV) who responded to carboplatin plus etoposide combination chemotherapy and discuss the relevant current literature.
原发性膀胱纯小细胞癌（SCCB）是一种极其罕见的肿瘤，占膀胱所有恶性肿瘤的比例不到1%。这种肿瘤比膀胱移行细胞癌表现出更具侵袭性的行为。不幸的是，这种恶性肿瘤的最佳治疗策略仍然未知。我们报告一例转移性原发性纯SCCB（IV期）患者，其对卡铂联合依托泊苷化疗有反应，并讨论相关的当前文献。
